COVID-19 (RECOVERY) で入院した患者におけるソトロビマブ対通常の治療:ランダム化,制御,オープンラベル,プラットフォーム試験
The Lancet. Infectious diseases
|August 31, 2025
まとめ
ソトロビマブは,高レベルのSARS-CoV-2抗原を有する入院COVID-19患者の死亡率を低下させた. しかし,その有効性は,現在の使用を制限する変異剤耐性のため,全体集団では見られなかった.
科学分野:
- 感染症
- 免疫学
- 臨床試験
背景:
- ソトロビマブは,SARS-CoV-2のスパイクタンパク質を標的とした中和性モノクローナル抗体です.
- RECOVERY試験では,入院したCOVID-19患者におけるソトロビマブの有効性と安全性を評価した.
研究 の 目的:
- 住院中のCOVID-19患者の死亡率を減らすためのソトロビマブの有効性を評価する.
- ソトロビマブ治療の安全性を評価する.
主な方法:
- イギリスの107の病院で1723人の患者を対象に個別にランダム化され,制御されたオープンラベル試験を行った.
- 患者は通常の治療とソトロビマブまたは通常の治療のみを受け,結果は28日間の死亡率で評価された.
- 患者は,血清のSARS-CoV-2核カプシド抗原レベル (高または低) によって分類された.
主要な成果:
- 抗原濃度が高い患者では,ソトロビマブにより28日間の死亡率が低下した (23% vs 29%; 率比0. 75).
- 死亡率の有意な減少は全患者集団で観察されなかった (21% 対 22%; 率比 0. 95).
- ソトロビマブを投与した患者の2%で注射反応が発生し,他の重大な安全性差異は認められなかった.
結論:
- ソトロビマブは,高レベルのSARS-CoV-2抗原を有する入院したCOVID-19患者のサブグループで有効性を示した.
- ソトロビマブの現在の臨床的有用性を制限している.
- 標的型中和抗体治療は,ワクチン接種とオミクロン流行にもかかわらず,依然として高リスク患者にとって有益である可能性があります.
さらに関連する動画
06:15Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
27.5K
07:25In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
17.8K
関連する概念動画
Clinical Trials
7.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
7.8K
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Controls in Experiments
10.4K
When conducting an experiment, it is crucial to have control to reduce bias and accurately measure the dependent variables. It also marks the results more reliable. Controls are elements in an experiment that have the same characteristics as the treatment groups but are not affected by the independent variable. By sorting these data into control and experimental conditions, the relationship between the dependent and independent variables can be drawn. A randomized experiment always includes a...
10.4K
Antimicrobial Effectiveness
156
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
156
Pneumonia IV: Management
445
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
445
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
